PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1994 May; 87(5): 256–258.
PMCID: PMC1294514

The prevention and management of haemolytic disease of the newborn.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (766K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Clarke CA. Preventing rhesus babies: the Liverpool research and follow up. Arch Dis Child. 1989 Dec;64(12):1734–1740. [PMC free article] [PubMed]
  • Nicolaides KH, Warenski JC, Rodeck CH. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. Am J Obstet Gynecol. 1985 Jun 1;152(3):341–344. [PubMed]
  • Urbaniak SJ, Greiss MA, Crawford RJ, Fergusson MJ. Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay. Vox Sang. 1984;46(5):323–329. [PubMed]
  • Nicolaides KH, Rodeck CH, Mibashan RS, Kemp JR. Have Liley charts outlived their usefulness? Am J Obstet Gynecol. 1986 Jul;155(1):90–94. [PubMed]
  • Nicolini U, Kochenour NK, Greco P, Letsky EA, Johnson RD, Contreras M, Rodeck CH. Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ. 1988 Nov 26;297(6660):1379–1381. [PMC free article] [PubMed]
  • Bowman JM. Treatment options for the fetus with alloimmune hemolytic disease. Transfus Med Rev. 1990 Jul;4(3):191–207. [PubMed]
  • de la Cámara C, Arrieta R, González A, Iglesias E, Omeñaca F. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med. 1988 Feb 25;318(8):519–520. [PubMed]
  • Margulies M, Voto LS, Mathet E, Margulies M. High-dose intravenous IgG for the treatment of severe rhesus alloimmunization. Vox Sang. 1991;61(3):181–189. [PubMed]
  • Bowman JM, Pollock JM. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures. Transfus Med Rev. 1987 Aug;1(2):101–112. [PubMed]
  • Tovey LA, Townley A, Stevenson BJ, Taverner J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet. 1983 Jul 30;2(8344):244–246. [PubMed]
  • Hussey RM, Clarke CA. Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989. BMJ. 1991 Aug 24;303(6800):445–446. [PMC free article] [PubMed]
  • Thomson A, Contreras M, Gorick B, Kumpel B, Chapman GE, Lane RS, Teesdale P, Hughes-Jones NC, Mollison PL. Clearance of Rh D-positive red cells with monoclonal anti-D. Lancet. 1990 Nov 10;336(8724):1147–1150. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press